Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
about
Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentagesAdjuvant therapy for resected pancreatic cancerRecent progress in pancreatic cancerRandomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question?A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinomaTotal pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data BaseManagement of pancreatic cancer in the elderlyAdjuvant therapy for pancreas cancer in an era of value based cancer careIrreversible electroporation and the pancreas: What we know and where we are going?Perspectives in the treatment of pancreatic adenocarcinomaNovel adjuvant therapies for pancreatic adenocarcinomaNeoadjuvant therapy for localized pancreatic cancer: guiding principlesPancreatic cancer: optimizing treatment options, new, and emerging targeted therapiesManagement of ampullary neoplasms: A tailored approach between endoscopy and surgeryPerioperative Therapy for Surgically Resectable Pancreatic AdenocarcinomaSmall bowel adenocarcinoma - report of two cases and review of literatureNeoadjuvant therapy for pancreas cancer: past lessons and future therapiesAmpullary cancer: an overviewAdjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinomaNew challenges in perioperative management of pancreatic cancerNovel advances in pancreatic cancer treatmentReversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cellsFluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection.Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the InterdisciplinaFinal results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma.Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancerAdjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.Evolution of systemic therapy for advanced pancreatic cancer.Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinomaConsensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.The addition of radiation to chemotherapy does not improve outcome when compared to chemotherapy in the treatment of resected pancreas cancer: the results of a single-institution experienceAdjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyPancreatic cancer: pathobiology, treatment options, and drug delivery.Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191
P2860
Q21092323-1C715317-97A0-41A7-A5AD-8927485CFE14Q24186323-839BCA75-CC50-4052-B599-9E9CA339F3D9Q24626346-0A58EC56-9527-473C-8E7A-242A5283818EQ24816432-16C5C8EA-1453-412E-AA65-05A1B56F588DQ26746031-2FAF54E8-49E5-4402-AFA5-E945A7D5DC04Q26748880-A0AEAC4E-1460-4285-86C4-665C1F1EA935Q26771577-4977643B-A66A-4265-89EC-386B6D601708Q26774639-5E28ED8A-2800-4EC5-ACAC-3B929353E4EBQ26775916-138C377D-72CD-403B-8D4D-FC52B3586EDCQ26795522-047B63F8-B385-4D34-A08B-2AF00A05AAD1Q26797248-39D0E393-04BA-4DCE-AB6C-1D1A9EA1EFA7Q26799425-16722192-3B49-4C72-A9D3-19B0599DAB49Q26799428-74744C97-9ED0-4041-A500-2C802B41F6D4Q26799714-35CF199D-0A1F-4950-A616-5DCD82C4C5CCQ26799743-776B8F0A-A418-4F3C-A96A-55E1A9FB84F6Q26801411-6D6AD486-E920-45B9-A4E4-7C0827EA1ACEQ26863289-F5826B55-5F32-4B94-8259-3A513DEECF5EQ27004292-5C057A1A-A65B-4A41-83E3-A23E4A6CB2B5Q27023881-DF944ECC-5140-4081-9755-557B3F2DC289Q28074614-D41E7FD6-123E-414C-90BA-A43D24DBF211Q28082422-8621719E-8957-40BC-A40E-8ED4DF5B7CB5Q28282794-A98389FD-6911-4862-B966-0BA56953A0F0Q28534611-DC5AC508-510D-40F2-A3E9-E328FC68D658Q30422810-8317B4C8-68A7-4C5C-91FC-8568ED4A047FQ30580152-D17742C3-D388-4194-9008-EE925DAF11F4Q30987695-54A3D1C2-02E0-424D-94C9-310C039EF5CCQ31041732-7075F07B-D5C5-45F6-A1E1-982271E2AC53Q33276956-2C625A98-029E-4CBC-BF17-DCF8F16E2CC1Q33367266-06C26E7B-6F05-479B-B344-1FB445030668Q33389524-F9CB88AE-437B-457F-BD91-51E5871076FFQ33403255-D831897C-3A70-47DC-9A3F-E07E65D0E6BCQ33506777-6378B858-A043-4859-A7E8-6115D5DA62A6Q33557413-4994ACD0-844B-405D-8219-133328E19D39Q33631833-34144220-15C8-4816-AC84-899E6A4C3D10Q33665450-2958F18B-81DA-4286-9A4E-50D11D13629BQ33699802-ED6CC7E3-B286-43E3-9FCB-CB0E5AE6CB4EQ33735469-840417AD-6AB3-4FE4-BF0C-E45DD2B466B0Q33749460-14536146-2AAB-4CAB-8ED6-231374B2FEA2Q33751263-AC26A01D-9102-4E4E-9E2A-48B807845867Q33755147-8F5EB8BE-3131-4E1C-95E7-CF93C0D91178
P2860
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@ast
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@en
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@nl
type
label
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@ast
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@en
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@nl
prefLabel
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@ast
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@en
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@nl
P2093
P2860
P921
P1433
P1476
Adjuvant radiotherapy and 5-fl ...... ract cancer cooperative group.
@en
P2093
A Hennipman
C H Veenhof
D G Gonzalez
J H Klinkenbijl
J P Arnaud
L T de Wit
M L Couvreur
P2860
P304
776-82; discussion 782-4
P356
10.1097/00000658-199912000-00006
P407
P577
1999-12-01T00:00:00Z